| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/21/2001 | WO2001044177A2 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 06/21/2001 | WO2000040275A3 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 06/21/2001 | WO1998010795A9 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 06/21/2001 | US20010004454 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 06/21/2001 | CA2395290A1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 06/21/2001 | CA2383936A1 Novel somatostatin analogs |
| 06/20/2001 | EP1107995A2 Bifunctional antibodies and their use in targeting anti-tumour agents |
| 06/20/2001 | EP1107979A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | CN1299833A Human vessel endothelium growth factor resisting single stranded antibody and its preparation |
| 06/19/2001 | US6248870 Unsymmetrical complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | US6248304 Piperidine compound |
| 06/19/2001 | US6248057 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 06/19/2001 | CA1341259C Particle vector useful as a carrier of biologically active molecules, and a fabrication method |
| 06/14/2001 | WO2001042586A1 A ventilating device for ventilating through a ridge |
| 06/14/2001 | WO2001042220A2 Podate ligands and methods of use thereof |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001041823A2 Radioactive compositions and methods of use thereof |
| 06/14/2001 | WO2001007089A3 Technetium tc99m teboroxime myokardial-perfusion mittel |
| 06/14/2001 | CA2393539A1 Radioactive compositions and methods of use thereof |
| 06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
| 06/13/2001 | EP1105528A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 06/13/2001 | EP1105164A2 Imaging with tc-99m labeled fibrin-alpha-chain peptide |
| 06/13/2001 | EP1105163A1 Methods for labeling beta-amyloid plaques and neurofibrillary tangles |
| 06/12/2001 | US6245317 F18-labeled oxa fatty acids and methods of making and using the same |
| 06/12/2001 | US6245316 Enhancement of delivery of radioimaging and radioprotective agents |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040239A2 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/07/2001 | WO2001039806A1 Receptor binding conjugates |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039744A2 Radiation sensitive liposomes |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | US20010002992 Imaging means comprising an imaging agent attached to an agent that binds to a cell surface element of a mononuclear phagocyte; therapy of cancer or coronary heart disease |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2393610A1 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/05/2001 | US6241965 Somatostatin derivatives and their radiolabelled products |
| 06/05/2001 | US6241964 F-18 radiolabeled neurokinin-1 receptor antagonists |
| 06/05/2001 | US6241963 Dopamine and serotonin transporter ligands and imaging agents |
| 06/05/2001 | US6241962 Radiopharmaceutical compositions and matrices and uses thereof |
| 06/05/2001 | US6241961 Administering to bone marrow of patient a dose of a monoclonal antibody or antibody fragment stably coupled to a cadmium-66 radioisotope; side effect reduction |
| 06/05/2001 | US6241719 Method for forming a radioactive stent |
| 05/31/2001 | WO2001037883A1 Complexes of alkylphosphonic acids |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | US20010002249 Luteinizing hormone releasing hormone (LHRH); reducing breast density for better imaging of breast tissue such as prior to mammograms |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2390802A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/30/2001 | EP1103234A1 A device for conveying radioactive agents on angioplasty stents, respective method and kit |
| 05/30/2001 | EP1102601A1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 05/29/2001 | US6238872 Inhibiting restenosis by inserting stent that has antigen attached, then administering antibody labeled with radioactive source; immunotherapy |
| 05/29/2001 | US6238644 Method for treating and/or imaging breast cancer using radioactive iodide |
| 05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
| 05/29/2001 | CA2054263C Process for preparing a radiopharmaceutical composition |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036485A2 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
| 05/25/2001 | WO2001036007A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 05/25/2001 | WO2001036006A1 Opioid metallopeptide compositions and methods |
| 05/25/2001 | WO2001036005A2 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | WO2000078362A3 Stable, radioactively marked nanoparticles, method for the production and utilization thereof |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2391450A1 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | CA2388844A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/25/2001 | CA2359577A1 Antibodies and fv fragment recognizing antigen ior c2 |
| 05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
| 05/23/2001 | EP1100473A2 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 05/22/2001 | US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine |
| 05/17/2001 | WO2001034651A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 05/17/2001 | WO2001034209A1 LIGANDS FOR α7 NICOTINIC ACETYLCHOLINE RECEPTORS BASED ON METHYLLYCACONITINE |
| 05/17/2001 | WO2001034194A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 05/17/2001 | WO2000078796A3 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 05/17/2001 | WO2000076550A3 Carrier-drug conjugate |
| 05/17/2001 | WO1999048536A3 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 05/17/2001 | CA2390412A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 05/17/2001 | CA2389386A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 05/16/2001 | EP1099707A2 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 05/16/2001 | EP1099693A1 Radiolabelled peptide compounds |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098665A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1098651A2 Novel urokinase inhibitors |
| 05/16/2001 | CN1295578A Pharmaceuticals for imaging of angiogenic disorders |
| 05/16/2001 | CN1065770C 99M TC-N, N'diamineethyl propylenediamino hexaacetic acid developer and use therefor |
| 05/16/2001 | CN1065769C Preparation of radiopharmaceutical |
| 05/15/2001 | US6232295 Cell-specific contrast agent and gene delivery vehicles |
| 05/15/2001 | US6232080 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231832 Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use |
| 05/15/2001 | US6231495 Radiation emitting, elastic hose for the endovascular therapy |
| 05/15/2001 | CA2291456A1 Diagnostic agents for pancreatic exocrine function |
| 05/15/2001 | CA2158054C Conjugates of proteins and bifunctional ligands |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/10/2001 | WO2001032624A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032070A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |